Health And Medicine
-
Study takes 3-D perspective on colorectal cancer
Despite dramatic recent advances in treatment, colorectal cancer killed more than 49,000 Americans last year, according to the National Cancer Institute, making it the second most lethal malignancy after cancers of the lung and bronchus. Read MoreMar 23, 2017
-
Blocking neuroblastoma cell growth
An inhibitor of cell metabolism may be a good therapeutic target for neuroblastoma, which accounts for about 15 percent of pediatric cancer-related deaths. Read MoreMar 22, 2017
-
Delirium in the ED
Interventions for delirium in the emergency department setting are needed to preserve patients’ long-term function and cognition, Vanderbilt investigators have found. Read MoreMar 20, 2017
-
MEDIA ADVISORY: Women in STEM panel seeks to define, overcome challenges
Alumna Kimberly Bryant, founder of Black Girls Code, will discuss the underrepresentation of women in STEM fields with Vanderbilt professors Alyssa Hasty, Bonnie Miller and Nicole Joseph. Read MoreMar 17, 2017
-
New target for colorectal cancer
Vanderbilt investigators have discovered that activated epidermal growth factor receptor may be a target for therapies to prevent colorectal cancer development. Read MoreMar 17, 2017
-
Study catches ‘notorious’ drug pump in action
Researchers at Vanderbilt University Medical Center (VUMC) have mapped the conformational changes that occur in a protein “notorious” for pumping chemotherapeutic drugs out of cancer cells and blocking medications from reaching the central nervous system. Read MoreMar 16, 2017
-
VUMC joins cutting-edge obesity research network
Vanderbilt University Medical Center (VUMC) is one of four centers receiving a $15 million, four-year research award from the American Heart Association (AHA) to provide cutting-edge research on obesity as part of its sixth Strategically Focused Research Network (SFRN). Read MoreMar 16, 2017
-
Premature infants in NICU do better with touch: study
Treatment in the Neonatal Intensive Care Unit (NICU) saves millions of infants born prematurely every year. But treatment is not without cost. Painful procedures such as needle pricks can impact early brain development. Read MoreMar 16, 2017
-
Esophageal cancer complexities
New findings that reveal complex interactions in esophageal adenocarcinoma could lead to diagnostic, prognostic or therapeutic biomarkers. Read MoreMar 16, 2017
-
Study explores alcohol use patterns in early pregnancy
The latest Centers for Disease Control and Prevention update recommending that women who are pregnant or could become pregnant abstain from alcohol use prompted a Vanderbilt professor of Obstetrics and Gynecology and her team to explore the patterns of alcohol use in early pregnancy. Read MoreMar 9, 2017
-
Certain risk factors linked to post-surgery infection
Plastic surgeons at Vanderbilt University Medical Center (VUMC) have published a prospective study that proves there are specific risk factors — such as obesity, smoking and diabetes — that contribute to development of a major surgical site infection following cosmetic surgery. Read MoreMar 9, 2017
-
Investigators use machine learning to predict suicide risk
According to the Centers for Disease Control and Prevention (CDC), in 2013 there were 41,149 suicides in the U.S., making it the 10th leading cause of death that year. Among high school students in 2013, the CDC estimates that over the previous 12 months 2.7 percent had sometime made a suicide attempt resulting in injury, poisoning or overdose that required medical attention. Read MoreMar 9, 2017
-
Melanoma study finds new way to enhance targeted therapies
With the help of a drug formerly used to treat HIV/AIDS, researchers at Vanderbilt University Medical Center (VUMC) have found a way to make melanoma cells more vulnerable to targeted anti-cancer therapy. Read MoreMar 9, 2017
-
Role for mouth microbes in diabetes?
A higher abundance of certain bacterial species in the mouth appears to reduce the risk of type 2 diabetes, Vanderbilt investigators have discovered. Read MoreMar 8, 2017
-
Antidote for smoke inhalation injury
Routine use of hydroxocobalamin should be considered for victims of smoke inhalation, Vanderbilt researchers suggest. Read MoreMar 7, 2017
-
Mutation raises heart block risk
A newly identified genetic risk factor for heart block after surgery may help guide the course of postoperative care. Read MoreMar 3, 2017
-
Clues found to recurrent depression
Women who have had repeated depressive episodes tend to pay more attention to negative emotional information, suggesting that they may benefit from cognitive therapy to build new, more positive pathways in their brains. Read MoreMar 2, 2017
-
Clinical investigation society lauds impact of Crowe’s research
James Crowe Jr., M.D., director of the Vanderbilt Vaccine Center, is the 2017 recipient of the Stanley J. Korsmeyer Award given by the American Society for Clinical Investigation (ASCI), one of the nation’s oldest and most respected honor societies for physician-scientists. Read MoreMar 2, 2017
-
Study reveals circadian time in a blood sample
A researcher at Vanderbilt has identified a set of 15 genes that together exhibit a 24-hour gene expression pattern in human blood, constituting a circadian clock biomarker. Read MoreMar 2, 2017
-
Investigators seek new way to define cell identity
Vanderbilt researchers hope their new method to describe cells will be widely adopted and used to generate a “Who’s Who” database of cell types. Read MoreMar 2, 2017